Morgan Stanley
GCTK icon

Morgan Stanley’s GlucoTrack GCTK Stock Holding History

Morgan Stanley’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$1 – 8486
2026
Q1 		– Hold
0
– – – 8278
2025
Q4 		– Sell
-27
Closed -$2.4K – 8163
2025
Q3 		$2.64K Buy
+27
New +$2.44K ﹤0.01% 7248
2025
Q2 		– Hold
0
– – – 8040
2025
Q1 		– Hold
0
– – – 8040
2024
Q4 		– Hold
0
– – – 7346
2024
Q3 		– Hold
0
– – – 7204

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley's GCTK Position: Q2 2026 in Review

Morgan Stanley held its GlucoTrack (GCTK) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8486.

Morgan Stanley first reported a position in GCTK in Q3 2025 and has held it in 1 quarter since. The position peaked at $2.64K in Q3 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Morgan Stanley held 0 shares of GlucoTrack worth $0 as of Q2 2026.
  • Morgan Stanley left its GlucoTrack share count unchanged in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8486 holding.
  • Morgan Stanley first reported a position in GlucoTrack in Q3 2025 and has held it in 1 quarter since.
  • Morgan Stanley's GlucoTrack position peaked at $2.64K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.